Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 14 May 2026 Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study PLOS Neglected Tropical Diseases
Scientific articles 30 Apr 2026 Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination npj Antimicrobials and Resistance
In the media 29 Apr 2026 ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด Thai Rath
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 25 Apr 2026 ‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África Alma Preta
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Press releases 9 May 2024 DNDi welcomes GHIT Fund’s renewed support to optimize novel compounds to treat Chagas disease
Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Press releases 30 Jan 2024 DNDi receives USD 20 million to develop innovative treatments to further elimination goals for sleeping sickness and river blindness
Press releases 10 Jan 2024 Clinical trial confirms the tolerability of the drug fexinidazole in the treatment of Chagas disease
Press releases 15 Dec 2023 EMA gives positive opinion to Fexinidazole Winthrop as first oral treatment of acute form of sleeping sickness (rhodesiense) found in East and Southern Africa
Press releases 8 Dec 2023 Nagasaki University, DNDi, and GHIT Fund sign agreement to collaborate on drug screening for Chagas disease
Press releases 5 Dec 2023 Cryptococcal meningitis: new report highlights slow uptake of guidelines shown to reduce deaths in Africa
Press releases 3 Dec 2023 Germany’s Federal Ministry for Economic Cooperation and Development (BMZ) through KfW grants funding to fast-track access to medicines for poverty-related and neglected diseases
Press releases 23 Nov 2023 World’s first clinical trial for devastating fungal disease mycetoma shows efficacy of new, promising treatment
Press releases 16 Oct 2023 DNDi signs memorandum of understanding with Spanish Agency for International Development Cooperation
Press releases 11 Oct 2023 DNDi receives 2023 Princess of Asturias Award for International Cooperation
Press releases 6 Sep 2023 Biotech leader Delali Attiogbe Attipoe joins DNDi as North America Director
Press releases 31 Jul 2023 Certara and DNDi partnering to fast-track data submissions and accelerate drug approvals for neglected patients
Press releases 20 Jul 2023 Fiocruz signs agreement to register hepatitis C medication with Brazilian health regulatory agency
